Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy

Amgen Net Income 2006-2018 | AMGN

Amgen annual/quarterly net income history and growth rate from 2006 to 2018. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
  • Amgen net income for the quarter ending December 31, 2018 was $1.928B, a 145.22% decline year-over-year.
  • Amgen net income for the twelve months ending December 31, 2018 was $8.394B, a 324.15% increase year-over-year.
  • Amgen annual net income for 2018 was $8.394B, a 324.15% increase from 2017.
  • Amgen annual net income for 2017 was $1.979B, a 74.37% decline from 2016.
  • Amgen annual net income for 2016 was $7.722B, a 11.28% increase from 2015.
Amgen Annual Net Income
(Millions of US $)
2018 $8,394
2017 $1,979
2016 $7,722
2015 $6,939
2014 $5,158
2013 $5,081
2012 $4,345
2011 $3,683
2010 $4,627
2009 $4,605
2008 $4,052
2007 $3,078
2006 $2,950
2005 $3,674
Amgen Quarterly Net Income
(Millions of US $)
Q4 2018 $1,928
Q3 2018 $1,859
Q2 2018 $2,296
Q1 2018 $2,311
Q4 2017 $-4,264
Q3 2017 $2,021
Q2 2017 $2,151
Q1 2017 $2,071
Q4 2016 $1,935
Q3 2016 $2,017
Q2 2016 $1,870
Q1 2016 $1,900
Q4 2015 $1,800
Q3 2015 $1,863
Q2 2015 $1,653
Q1 2015 $1,623
Q4 2014 $1,294
Q3 2014 $1,244
Q2 2014 $1,547
Q1 2014 $1,073
Q4 2013 $1,021
Q3 2013 $1,368
Q2 2013 $1,258
Q1 2013 $1,434
Q4 2012 $788
Q3 2012 $1,107
Q2 2012 $1,266
Q1 2012 $1,184
Q4 2011 $934
Q3 2011 $454
Q2 2011 $1,170
Q1 2011 $1,125
Q4 2010 $1,022
Q3 2010 $1,236
Q2 2010 $1,202
Q1 2010 $1,167
Q4 2009 $931
Q3 2009 $1,386
Q2 2009 $1,269
Q1 2009 $1,019
Q4 2008 $925
Q3 2008 $1,121
Q2 2008 $906
Q1 2008 $1,100
Q4 2007 $747
Q3 2007 $201
Q2 2007 $1,019
Q1 2007 $1,111
Q4 2006 $833
Q3 2006 $1,102
Q2 2006 $14
Q1 2006 $1,001
Q4 2005 $824
Q3 2005 $967
Q2 2005 $1,029
Q1 2005 $854
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $119.048B $23.747B
Amgen Inc. discovers, develops and delivers innovative human therapeutics. A biotechnology pioneer, Amgen was one of the first companies to realize the new science's promise by bringing safe and effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people's lives.
Stock Name Country Market Cap PE Ratio
Gilead Sciences (GILD) United States $82.934B 10.56
Biogen (BIIB) United States $64.057B 12.41
Celgene (CELG) United States $61.800B 11.43
Vertex Pharmaceuticals (VRTX) United States $47.931B 64.21
Illumina (ILMN) United States $44.950B 53.46
Regeneron Pharmaceuticals (REGN) United States $44.541B 20.69
Alexion Pharmaceuticals (ALXN) United States $29.835B 18.49
Incyte (INCY) United States $18.327B 171.24
BioMarin Pharmaceutical (BMRN) United States $16.653B 0.00
Seattle Genetics (SGEN) United States $11.793B 0.00
Exact Sciences (EXAS) United States $11.561B 0.00
Alnylam Pharmaceuticals (ALNY) United States $9.589B 0.00
Bio-Rad Laboratories (BIO.B) United States $9.298B 53.05
Sarepta Therapeutics (SRPT) United States $9.041B 0.00
QIAGEN (QGEN) Netherlands $8.950B 29.62
Bluebird Bio (BLUE) United States $8.582B 0.00
BeiGene (BGNE) Cayman Islands $8.021B 0.00
Guardant Health (GH) United States $8.018B 0.00
Bio-Techne Corp (TECH) United States $7.430B 50.06
Moderna (MRNA) United States $7.297B 0.00
Exelixis (EXEL) United States $7.245B 16.88
Amarin (AMRN) Ireland $6.232B 0.00
Ascendis Pharma (ASND) Denmark $5.428B 0.00
Alkermes (ALKS) Ireland $5.401B 0.00
Galapagos (GLPG) Belgium $5.181B 0.00
Array BioPharma (ARRY) United States $5.180B 0.00
Horizon Pharma Public (HZNP) Ireland $4.692B 15.11
Spark Therapeutics (ONCE) United States $4.326B 0.00
ARGENX SE-ADR (ARGX) Netherlands $4.304B 0.00
ACADIA Pharmaceuticals (ACAD) United States $3.899B 0.00
Blueprint Medicines (BPMC) United States $3.644B 0.00
Immunomedics (IMMU) United States $3.588B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.505B 0.00
China Biologic Products (CBPO) China $3.423B 21.21
Intercept Pharmaceuticals (ICPT) United States $3.372B 0.00
Allogene Therapeutics (ALLO) United States $3.259B 0.00
Amicus Therapeutics (FOLD) United States $3.027B 0.00
MorphoSys AG Unsponsored ADR (MOR) Germany $2.982B 0.00
Global Blood Therapeutics (GBT) United States $2.979B 0.00
Reata Pharmaceuticals (RETA) United States $2.832B 0.00
Genomic Health (GHDX) United States $2.739B 70.03
Akcea Therapeutics (AKCA) United States $2.694B 0.00
Mirati Therapeutics (MRTX) United States $2.691B 0.00
Repligen (RGEN) United States $2.609B 80.28
Ligand Pharmaceuticals (LGND) United States $2.548B 19.03
Emergent Biosolutions (EBS) United States $2.536B 21.17
Myriad Genetics (MYGN) United States $2.485B 25.31
UniQure (QURE) Netherlands $2.475B 0.00
Acceleron Pharma (XLRN) United States $2.425B 0.00
Halozyme Therapeutics (HALO) United States $2.396B 0.00
Denali Therapeutics (DNLI) United States $2.329B 0.00
Insmed (INSM) United States $2.307B 0.00
Arena Pharmaceuticals (ARNA) United States $2.274B 0.00
Biohaven Pharmaceutical Holding (BHVN) United States $2.188B 0.00
MyoKardia (MYOK) United States $2.172B 0.00
REGENXBIO (RGNX) United States $2.125B 22.19
Medicines (MDCO) United States $2.004B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $1.980B 0.00
AnaptysBio (ANAB) United States $1.970B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.929B 0.00
NeoGenomics (NEO) United States $1.868B 151.92
Atara Biotherapeutics (ATRA) United States $1.809B 0.00
Zai Lab Unsponsored ADR (ZLAB) China $1.737B 0.00
Allakos (ALLK) United States $1.710B 0.00
Audentes Therapeutics (BOLD) United States $1.644B 0.00
Puma Biotechnology (PBYI) United States $1.631B 0.00
Myovant Sciences (MYOV) United Kingdom $1.594B 0.00
WAVE Life Sciences (WVE) Singapore $1.589B 0.00
Clovis Oncology (CLVS) United States $1.453B 0.00
Orchard Therapeutics Sponsored ADR (ORTX) United Kingdom $1.446B 0.00
Innoviva (INVA) United States $1.434B 3.95
Momenta Pharmaceuticals (MNTA) United States $1.431B 0.00
GOSSAMER BIO (GOSS) United States $1.398B 0.00
Aimmune Therapeutics (AIMT) United States $1.393B 0.00
Rubius Therapeutics (RUBY) United States $1.386B 0.00
Cambrex (CBM) United States $1.328B 14.29
ALECTOR INC (ALEC) United States $1.286B 0.00
Lion Biotechnologies (IOVA) United States $1.277B 0.00
Apellis Pharmaceuticals (APLS) United States $1.249B 0.00
Fate Therapeutics (FATE) United States $1.194B 0.00
Editas Medicine (EDIT) United States $1.177B 0.00
RA PHARMCTL INC (RARX) United States $1.134B 0.00
Codexis (CDXS) United States $1.128B 0.00
Epizyme (EPZM) United States $1.113B 0.00
InflaRx (IFRX) Germany $1.089B 0.00
Rhythm Pharmaceuticals (RYTM) United States $1.042B 0.00
Coherus BioSciences (CHRS) United States $1.032B 0.00
Sangamo Therapeutics (SGMO) United States $1.002B 0.00
Autolus Therapeutics Sponsored ADR (AUTL) United Kingdom $0.994B 0.00
Retrophin (RTRX) United States $0.992B 0.00
Clementia Pharmaceuticals (CMTA) Canada $0.983B 0.00
Deciphera Pharmaceuticals (DCPH) United States $0.970B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $0.966B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.959B 38.77
Alder BioPharmaceuticals (ALDR) United States $0.939B 0.00
Dicerna Pharmaceuticals (DRNA) United States $0.894B 0.00
Principia Biopharma (PRNB) United States $0.872B 0.00
Vericel (VCEL) United States $0.843B 0.00
Athenex (ATNX) United States $0.831B 0.00
Cellectis (CLLS) France $0.822B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.814B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.810B 0.00
Intellia Therapeutics (NTLA) United States $0.756B 0.00
Cara Therapeutics (CARA) United States $0.754B 0.00
ANI Pharmaceuticals (ANIP) United States $0.751B 13.75
Eidos Therapeutics (EIDX) United States $0.742B 0.00
Inotek Pharmaceuticals (RCKT) United States $0.723B 0.00
Nightstar Therapeutics Sponsored ADR (NITE) United Kingdom $0.712B 0.00
Intra-Cellular Therapies (ITCI) United States $0.707B 0.00
Revance Therapeutics (RVNC) United States $0.704B 0.00
Synthorx (THOR) United States $0.691B 0.00
Acorda Therapeutics (ACOR) United States $0.685B 8.88
Osiris Therapeutics (OSIR) United States $0.657B 0.00
Heska (HSKA) United States $0.632B 56.66
ZIOPHARM Oncology Inc (ZIOP) United States $0.625B 0.00
Twist Bioscience (TWST) United States $0.613B 0.00
Magenta Therapeutics (MGTA) United States $0.612B 0.00
Viking Therapeutics (VKTX) United States $0.612B 0.00
Kura Oncology (KURA) United States $0.609B 0.00
G1 THERAPEUTICS (GTHX) United States $0.596B 0.00
ObsEva SA (OBSV) Switzerland $0.585B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.582B 0.00
MeiraGTx Holdings (MGTX) United States $0.581B 0.00
Prothena (PRTA) Ireland $0.578B 0.00
Arvinas (ARVN) United States $0.534B 0.00
NuCana Sponsored ADR (NCNA) United Kingdom $0.525B 0.00
UROGEN PHARMA (URGN) Israel $0.524B 0.00
Arcus Biosciences (RCUS) United States $0.524B 0.00
Senesco Technologies (ELOX) United States $0.500B 0.00
Dynavax Technologies (DVAX) United States $0.498B 0.00
Zymeworks (ZYME) Canada $0.497B 0.00
Mesoblast (MESO) Australia $0.487B 0.00
DBV Technologies (DBVT) France $0.486B 0.00
CytomX Therapeutics (CTMX) United States $0.485B 0.00
Zealand Pharma (ZEAL) Denmark $0.482B 5.31
Scholar Rock Holding (SRRK) United States $0.481B 0.00
PDL BioPharma (PDLI) United States $0.465B 10.37
Five Prime Therapeutics (FPRX) United States $0.461B 0.00
Cytokineticsorporated (CYTK) United States $0.452B 0.00
Anika Therapeutics (ANIK) United States $0.433B 16.39
AMAG Pharmaceuticals (AMAG) United States $0.432B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.424B 0.00
AVROBIO (AVRO) United States $0.422B 0.00
Urovant Sciences (UROV) United States $0.420B 0.00
Replimune (REPL) United States $0.416B 0.00
Stemline Therapeutics (STML) United States $0.410B 0.00
MannKind (MNKD) United States $0.403B 0.00
STEALTH BIOTHER (MITO) United States $0.390B 0.00
Abeona Therapeutics (ABEO) United States $0.388B 0.00
Gritstone Oncology (GRTS) United States $0.387B 0.00
BeyondSpring (BYSI) United States $0.384B 0.00
Axsome Therapeutics (AXSM) United States $0.382B 0.00
Albireo Pharma (ALBO) United States $0.373B 0.00
UNITY Biotechnology (UBX) $0.372B 0.00
Sinovac Biotech (SVA) China $0.371B 0.00
Solid Biosciences (SLDB) United States $0.369B 0.00
Kadmon Holdings (KDMN) United States $0.369B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.366B 0.00
MediciNova (MNOV) United States $0.364B 0.00
Adverum Biotechnologies (ADVM) United States $0.357B 0.00
Kezar Life Sciences (KZR) United States $0.355B 0.00
XBiotech (XBIT) United States $0.355B 0.00
BioDelivery Sciences (BDSI) United States $0.348B 0.00
Agenus (AGEN) United States $0.346B 0.00
Kindred Biosciences (KIN) United States $0.344B 0.00
Inovio Pharmaceuticals (INO) United States $0.344B 0.00
Sorrento Therapeutics (SRNE) United States $0.336B 0.00
OSMOTICA PHARM (OSMT) United States $0.325B 0.00
Aduro Biotech (ADRO) United States $0.319B 0.00
Cellular Biomedicine (CBMG) United States $0.314B 0.00
Krystal Biotech (KRYS) United States $0.307B 0.00
Geron (GERN) United States $0.306B 0.00
AC Immune SA (ACIU) Switzerland $0.305B 0.00
Strongbridge Biopharma (SBBP) United States $0.294B 0.00
Syros Pharmaceuticals (SYRS) United States $0.294B 0.00
Merus (MRUS) Netherlands $0.290B 0.00
Kala Pharmaceuticals (KALA) United States $0.289B 0.00
Protagonist Therapeutics (PTGX) United States $0.284B 0.00
Gamida Cell (GMDA) Israel $0.277B 0.00
Evelo Biosciences (EVLO) United States $0.276B 0.00
Liquidia Technologies (LQDA) United States $0.275B 0.00
Seres Therapeutics (MCRB) United States $0.270B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.269B 0.00
Biofrontera AG Sponsored ADR (BFRA) Germany $0.268B 0.00
Enochian BioSciences (ENOB) United States $0.265B 0.00
Constellation Pharmaceuticals (CNST) United States $0.258B 0.00
Kodiak Sciences (KOD) United States $0.257B 0.00
Sutro Biopharma (STRO) United States $0.257B 0.00
ResTORbio (TORC) United States $0.254B 0.00
Verastem (VSTM) United States $0.250B 0.00
TOCAGEN INC (TOCA) United States $0.249B 0.00
BioTime (BTX) United States $0.243B 0.00
Mersana Therapeutics (MRSN) United States $0.241B 0.00
Kamada (KMDA) Israel $0.238B 10.74
Peregrine Pharmaceuticals (CDMO) United States $0.237B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.236B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.234B 0.00
Cerecor (CERC) United States $0.233B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.231B 0.00
Athersys (ATHX) United States $0.225B 0.00
LogicBio Therapeutics (LOGC) United States $0.224B 0.00
Spero Therapeutics (SPRO) United States $0.222B 0.00
Intec Pharma (NTEC) Israel $0.222B 0.00
ChromaDex (CDXC) United States $0.221B 0.00
Arbutus Biopharma (ABUS) Canada $0.217B 0.00
Axovant Sciences (AXGT) United Kingdom $0.216B 0.00
Celyad SA (CYAD) Belgium $0.216B 0.00
Proteostasis Therapeutics (PTI) United States $0.213B 0.00
Celcuity (CELC) United States $0.206B 0.00
Synlogic (SYBX) United States $0.203B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.203B 0.00
Palatin Technologies (PTN) United States $0.202B 99.25
CorMedix Inc (CRMD) United States $0.200B 0.00
Novavax (NVAX) United States $0.199B 0.00
ADMA Biologics Inc (ADMA) United States $0.197B 0.00
Compugen (CGEN) Israel $0.195B 0.00
VBI Vaccines (VBIV) United States $0.193B 0.00
Menlo Therapeutics (MNLO) United States $0.186B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.181B 0.00
Cue Biopharma (CUE) United States $0.177B 0.00
OvaScience (MLND) United States $0.176B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.175B 0.00
BioXcel Therapeutics (BTAI) United States $0.162B 0.00
Chiasma (CHMA) United States $0.159B 0.00
Allena Pharmaceuticals (ALNA) United States $0.158B 0.00
Pfenex (PFNX) United States $0.155B 0.00
Trevena (TRVN) United States $0.154B 0.00
PHASEBIO PHARMA (PHAS) United States $0.153B 0.00
Erytech Pharma SA Sponsored ADR (ERYP) France $0.152B 0.00
Cohbar (CWBR) United States $0.148B 0.00
Anavex Life Sciences (AVXL) United States $0.142B 0.00
Aptinyx (APTX) United States $0.141B 0.00
Eton Pharmaceuticals (ETON) United States $0.134B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.134B 0.00
Unum Therapeutics (UMRX) United States $0.130B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.130B 0.00
Organovo Holdings (ONVO) United States $0.129B 0.00
XOMA (XOMA) United States $0.128B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.126B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.124B 0.00
Equillium (EQ) United States $0.122B 0.00
Enzo Biochem (ENZ) United States $0.120B 0.00
Pluristem Therapeutics (PSTI) Israel $0.116B 0.00
Catalyst Biosciences (CBIO) United States $0.114B 0.00
VolitionRX (VNRX) Singapore $0.113B 0.00
Fortress Biotech (FBIO) United States $0.113B 0.00
Mustang Bio (MBIO) United States $0.112B 0.00
Checkpoint Therapeutics (CKPT) United States $0.106B 0.00
Neothetics (EVFM) United States $0.103B 0.00
NantKwest (NK) United States $0.096B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.095B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.094B 0.00
VTv Therapeutics (VTVT) United States $0.092B 0.00
Cel-Sci (CVM) United States $0.089B 0.00
Signal Genetics (MGEN) United States $0.088B 0.00
Idera Pharmaceuticals (IDRA) United States $0.086B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.085B 0.00
Cocrystal Pharma (COCP) United States $0.084B 93.80
Brainstorm Cell Therapeutics (BCLI) United States $0.083B 0.00
Aptose Biosciences (APTO) Canada $0.083B 0.00
Alimera Sciences (ALIM) United States $0.082B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.082B 0.00
Provention Bio (PRVB) United States $0.081B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $0.081B 0.00
Orgenesis (ORGS) United States $0.077B 0.00
Applied Genetic Technologies (AGTC) United States $0.077B 0.00
OVID THERAPEUTC (OVID) United States $0.075B 0.00
INMUNE BIO INC (INMB) United States $0.075B 0.00
ARAVIVE, INC (ARAV) United States $0.074B 0.00
SESEN BIO, INC (SESN) United States $0.074B 0.00
Protalix BioTherapeutics (PLX) Israel $0.072B 0.00
NewLink Genetics (NLNK) United States $0.070B 0.00
Proteon Therapeutics (PRTO) United States $0.070B 0.00
Cidara Therapeutics (CDTX) United States $0.070B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.070B 0.00
Selecta Biosciences (SELB) United States $0.069B 0.00
Tiziana Life Sciences Sponsored ADR (TLSA) United Kingdom $0.068B 0.00
Eyenovia (EYEN) United States $0.067B 0.00
AEterna Zentaris (AEZS) United States $0.066B 12.50
Prima BioMed (IMMP) Australia $0.065B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.065B 0.00
Ophthotech (OPHT) United States $0.065B 0.00
Vascular Biogenics (VBLT) Israel $0.061B 0.00
Celldex Therapeutics (CLDX) United States $0.059B 0.00
ScPharmaceuticals (SCPH) United States $0.058B 0.00
Sienna Biopharmaceuticals (SNNA) United States $0.058B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.057B 0.00
Alcobra (ARCT) United States $0.057B 0.00
VistaGen Therapeutics (VTGN) United States $0.056B 0.00
Zosano Pharma (ZSAN) United States $0.056B 0.00
Arsanis (XFOR) United States $0.055B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.052B 0.00
ANCHIANO THERAP (ANCN) Israel $0.052B 0.00
Clearside Biomedical (CLSD) United States $0.051B 0.00
Evogene (EVGN) Israel $0.050B 0.00
Leap Therapeutics (LPTX) United States $0.050B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.050B 0.00
VIVUS (VVUS) United States $0.049B 0.00
Bionano Genomics (BNGO) United States $0.049B 0.00
Bellerophon Therapeutics (BLPH) United States $0.048B 0.00
Entera Bio (ENTX) Israel $0.047B 0.00
Curis (CRIS) United States $0.047B 0.00
Vaccinex (VCNX) United States $0.046B 0.00
TRACON Pharmaceuticals (TCON) United States $0.045B 0.00
AquaBounty Technologies (AQB) United States $0.043B 0.00
Celsion (CLSN) United States $0.040B 0.00
DiaMedica Therapeutics (DMAC) United States $0.040B 0.00
OncoMed Pharmaceuticals (OMED) United States $0.038B 0.00
Caladrius Biosciences (CLBS) United States $0.037B 0.00
AZURRX BIOPHARM (AZRX) United States $0.036B 0.00
OncoSec Medical (ONCS) United States $0.036B 0.00
Moleculin Biotech (MBRX) United States $0.036B 0.00
Sophiris Bio (SPHS) United States $0.033B 0.00
GTx (GTXI) United States $0.032B 0.00
Oncolytics Biotech (ONCY) Canada $0.031B 0.00
GENPREX INC (GNPX) United States $0.031B 0.00
BiondVax Pharmaceuticals (BVXV) Israel $0.031B 0.00
Aileron Therapeutics (ALRN) United States $0.031B 0.00
Galena Biopharma (SLS) United States $0.030B 0.00
Advaxis (ADXS) United States $0.030B 0.00
Adial Pharmaceuticals (ADIL) United States $0.029B 0.00
Oragenics (OGEN) United States $0.028B 0.00
Rexahn Pharmaceuticals (RNN) United States $0.027B 0.00
BioPharmX (BPMX) United States $0.026B 0.00
Vical (VICL) United States $0.025B 0.00
IMMURON LTD (IMRN) Australia $0.024B 0.00
Dare Bioscience (DARE) United States $0.024B 0.00
CytRx (CYTR) United States $0.024B 0.00
Motif Bio Plc (MTFB) United States $0.023B 0.00
Titan Pharmaceuticals (TTNP) United States $0.023B 0.00
Novelion Therapeutics (NVLN) Canada $0.023B 0.00
Aytu Bioscience (AYTU) United States $0.021B 0.00
Benitec Biopharma (BNTC) Australia $0.020B 0.00
Cleveland BioLabs (CBLI) United States $0.020B 0.00
Aptevo Therapeutics (APVO) United States $0.020B 0.00
Fibrocell Science Inc (FCSC) United States $0.018B 0.00
Novogen (KZIA) Australia $0.018B 0.00
Prana Biotechnology (PRAN) Australia $0.017B 0.00
IBio (IBIO) United States $0.017B 0.00
RestorGenex (DFFN) United States $0.017B 0.00
Apricus Biosciences (SEEL) United States $0.016B 0.00
Soligenix (SNGX) United States $0.016B 0.00
TrovaGene (TROV) United States $0.016B 0.00
Gemphire Therapeutics (GEMP) United States $0.016B 0.00
Therapix Biosciences (TRPX) Israel $0.015B 7.75
Genetic Technologies (GENE) Australia $0.015B 0.00
Pulmatrix (PULM) United States $0.015B 0.00
ATyr Pharma (LIFE) United States $0.014B 0.00
Alliqua BioMedical (ALQA) United States $0.014B 0.00
Synthetic Biologics (SYN) United States $0.012B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.011B 0.00
AmpliPhi Biosciences (APHB) United States $0.011B 0.00
Neuralstem (CUR) United States $0.010B 0.00
MYOS RENS Technology (MYOS) United States $0.010B 0.00
Vital Therapies (VTL) United States $0.009B 0.00
Hemispherx BioPharma (HEB) United States $0.008B 0.00
Flex Pharma (FLKS) United States $0.008B 0.00
Histogenics (HSGX) United States $0.007B 0.00
ARCA Biopharma (ABIO) United States $0.007B 0.00
Stellar Biotechnologies (SBOT) United States $0.006B 0.00
Cellect Biotechnology (APOP) Israel $0.006B 0.00
ContraVir Pharmaceuticals Inc (CTRV) United States $0.005B 0.00
Cytori Therapeutics Inc (CYTX) United States $0.004B 0.00
Tenax Therapeutics (TENX) United States $0.003B 0.00
HOTH THERAPEUTC (HOTH) United States $0.000B 0.00
Oncobiologics (OTLK) United States $0.000B 0.00